The stage I non-small-cell lung cancer
Symposium Chairs: Dragan R. Subotic (Belgrade, Republic of Serbia), Nicolas Schönfeld (Berlin, Germany)
Aims: This session aims to provide a comprehensive and updated overview of issues related to early stage lung cancer that are still being debated. These issues include the optimal diagnostics, the benefits of molecular diagnostics and biomarkers, the factors that influence the treatment outcome, and the rapidly changing spectrum of surgical options for stage I NSCLC.